Skip to main content
. 2017 Jul 13;8:1457–1468. doi: 10.3762/bjnano.8.145

Table 3.

Associated drug (%) and entrapment drug quantity (µg/mg) of amphiphilic CD nanoparticles for PCX (CD amount is 0.5 mg/mL and initial PCX amount is 0.05 mg/mL in all formulations) (n = 3, ± SD).

Nanoparticle formulations Percentage associated drug ± SD Entrapment drug quantity ± SD (µg/mg)

6OCaproβCD 41 ± 2 4.4 ± 0.4
CS-6OCaproβCD 62 ± 5 5.6 ± 1.3
PC βCDC6 64 ± 2 6.3 ± 0.7